Dr. John C. ShershowAdult ADHD PsychiatryBook: (212) 265-4310
Menu

Key points

  • PMDD affects up to 5% of women of childbearing age and causes severe irritability, depression or anxiety in the week or two before a period (Office on Women's Health).
  • In a 2025 online survey, provisional PMDD screened positive in 31.4% of women with a self-reported ADHD diagnosis versus 9.8% of a non-ADHD group.
  • In 32 regularly cycling women, falling estradiol alongside rising progesterone or testosterone was followed by more ADHD symptoms the next day.
  • Premenstrual stimulant adjustment has been reported only in a nine-woman case study, with no comparison group.
  • Meta-analyses link PMDD to higher risk of suicidal thoughts and attempts.

Some weeks your usual routines and medication seem to work. Then, in the days before a period, focus slips, patience runs out and the same tasks feel impossible. Many women with ADHD describe this pattern. Research is starting to catch up, though much of it is small or based on self-reported surveys. This page covers what hormones appear to do, how often PMDD and ADHD occur together, and what is and is not known about adjusting medication around the cycle.

PMDD can include thoughts of suicide. If you have them at any point in your cycle, call or text 988, the Suicide and Crisis Lifeline. In a life-threatening emergency, call 911.

What PMDD is

The US Office on Women's Health (OWH) describes premenstrual dysphoric disorder as similar to premenstrual syndrome but more serious. It causes severe irritability, depression or anxiety in the week or two before a period, and symptoms usually go away two to three days after the period starts. It affects up to 5% of women of childbearing age. Researchers do not know its exact cause. Hormonal changes across the cycle may play a role, and so may serotonin, with some women possibly more sensitive to these changes.

Diagnosis depends on timing. OWH says you will need to keep a calendar or diary of symptoms and have five or more PMDD symptoms, including one that is mood-related. A sense that "the week before is always awful" is worth raising, but a daily record is what shows the pattern.

What hormones may do to ADHD symptoms

The most cited study is small. Roberts and colleagues followed 32 regularly cycling young women, recruited from a university and the surrounding community, for 35 days using daily saliva samples and evening symptom checklists. The study counted symptoms in a community sample, not women diagnosed with ADHD, and excluded prescribed stimulant users. Lower estradiol, in the context of higher progesterone or testosterone, was associated with more ADHD symptoms the next day, particularly in women high in impulsivity. Symptoms appeared to rise in the early follicular and early luteal phases. That is an association in a small group, and it does not show what any one person will experience.

A 2025 review of practical tools by Wynchank and colleagues says many women report cyclical changes in symptom intensity and reduced stimulant effect during the late luteal phase. It says periods of lower estrogen are believed to affect dopamine signaling negatively, and it recommends tracking the cycle along with mood and sleep. The authors note that more research is sorely needed. Clinical experience and belief are doing some of the work here, and that should be said openly.

How often PMDD and ADHD occur together

StudyWho was studiedFinding
Dorani et al., 2021209 consecutive women with ADHDPrevalence of PMDD symptoms was high compared with the general population; a later paper reports the figure as 45.5% with provisional PMDD
Broughton et al., 2025715 people aged 18 to 34 assigned female at birth, online surveyProvisional PMDD in 31.4% with self-reported ADHD diagnosis and 41.1% with ADHD by symptom threshold, versus 9.8% in a non-ADHD group
Tsuji et al., 20262,000 full-time employed women in JapanADHD traits carried an adjusted odds ratio of 6.49 for PMDD
Lin et al., 202458 women with PMDD and 50 controlsWomen with PMDD were more likely to have ADHD and showed more inattention across the cycle

These findings point in one direction, with important limits. Most rely on screening tools that identify provisional PMDD, without daily tracking across cycles. In the Broughton survey, risk was highest in people with ADHD symptoms plus a depression or anxiety diagnosis (relative risk 4.53). A 2026 study by Groenman and colleagues again found elevated provisional rates, and it warned that prevalence estimates are only as reliable as the recruitment behind them. People who join a study about periods may be the ones most troubled by them.

Telling the conditions apart

Overlap runs both ways. Lin's team found that women with PMDD, including those without ADHD, had a greater rise in memory and focus complaints in the days before a period than controls. So premenstrual trouble concentrating does not, by itself, suggest ADHD. Clinicians weigh several clues:

  • ADHD needs symptoms that began before age 12, according to the National Institute of Mental Health (NIMH), which describes them as persistent, occurring across multiple situations and lasting at least 6 months.
  • PMDD follows the cycle and clears within days after a period starts.
  • Both can be present. Lin's group found that women with both had more inattention and impulsivity even in phases well before the period.
  • Depression and anxiety can also sit underneath. OWH notes that many women with PMDD also have anxiety or depression. See ADHD or depression.

The guide's page on ADHD in women explains why ADHD is often recognized late, and the page on ADHD, perimenopause and menopause covers the later hormonal transition, where the evidence is also limited.

Cycle-adjusted stimulant dosing: preliminary data only

The evidence here is a community case study from a Dutch adult ADHD clinic, published by de Jong and colleagues in 2023. Nine women who reported premenstrual worsening had their individually prescribed stimulant dosage raised in the premenstrual period and were followed for 6 to 24 months. All nine reported improved ADHD and mood symptoms with minimal adverse events, and all chose to continue.

Nine cases with no comparison group cannot show that the change caused the improvement, and expectation may play a part. The authors themselves describe the results as preliminary, say implementation should be explored individually, and call for further study of safety. No controlled trial of this approach was found while researching this page as of November 2026.

This is not a suggestion to change your own medication. Stimulants are controlled medications. FDA labels warn that stimulant misuse can result in overdose and death, and taking more than prescribed can also leave you short before your next prescription. If your medication seems to fade before your period, keep a record and bring it to your prescriber. The page on whether an ADHD medication dose is too low or too high explains how prescribers think about this in general.

What to track

Wynchank's group recommends menstrual cycle tracking in assessment. A simple daily record over a few cycles might include:

  • The first day of your period and any spotting
  • Focus, restlessness, irritability and mood, each rated on a simple scale
  • Sleep
  • When you took any medication and how long it seemed to last
  • Hormonal contraception, pregnancy or perimenopause, since these change the picture
  • Any thoughts of self-harm, which call for help right away and should not wait for a tracking chart

The guide to preparing for an ADHD evaluation has more on what to bring.

Suicidal thoughts in PMDD

This risk deserves a direct statement. A 2021 meta-analysis by Prasad and colleagues found that women with PMDD were almost seven times as likely to have attempted suicide and almost four times as likely to report suicidal ideation as women without premenstrual disturbance. A second 2021 meta-analysis by Yan and colleagues found smaller but still raised risks, with odds ratios of 2.13 for attempts and 2.34 for ideation, and it noted that PMDD diagnoses in the included studies should be considered provisional. Either way, these thoughts deserve care now. Call or text 988.

Treatment for PMDD

OWH lists SSRI antidepressants, three of which the FDA has approved for PMDD, and a birth control pill containing drospirenone and ethinyl estradiol. It also says healthy food choices and more physical activity may relieve some symptoms, while PMDD can be serious enough that some women should see a doctor or nurse to discuss treatment. An adult ADHD evaluation asks about your health history and medications, and the menstrual pattern is useful to mention. Dr. Shershow evaluates and treats adults with ADHD located in New York or New Jersey. You can read more about the adult ADHD evaluation.

Questions

Can ADHD get worse before a period?

Many women report this, and small studies link hormone shifts to more ADHD symptoms. A 2025 review also describes reports of reduced stimulant effect in the late luteal phase. The research is limited, so daily tracking over several cycles is useful.

Is PMDD more common in women with ADHD?

Surveys suggest so. In a 2025 online survey, 31.4% of women with a self-reported ADHD diagnosis screened positive for provisional PMDD, compared with 9.8% of a non-ADHD group. These are screening results, not confirmed diagnoses, and study recruitment can raise the numbers.

Should I take more stimulant the week before my period?

Do not adjust it on your own. The evidence is a case study of nine women with no comparison group, carried out under clinician monitoring. Bring your symptom record to your prescriber to discuss the pattern.

Does PMDD cause suicidal thoughts?

It can. The Office on Women's Health lists thoughts of suicide among PMDD symptoms, and meta-analyses link PMDD with higher risk of suicidal thoughts and attempts. Call or text 988 if this happens, at any point in your cycle.

Who treats PMDD?

The Office on Women's Health advises speaking to a doctor or nurse about treatment. Options it lists include certain SSRI antidepressants and a specific birth control pill.

Sources

  1. US Office on Women's Health: Premenstrual dysphoric disorder (PMDD)
  2. Roberts, Eisenlohr-Moul and Martel, Psychoneuroendocrinology: Reproductive steroids and ADHD symptoms across the menstrual cycle (2018)
  3. Wynchank et al., European Psychiatry: Practical tools for female-specific ADHD, the impact of hormonal fluctuations (2025)
  4. Dorani et al., Journal of Psychiatric Research: Prevalence of hormone-related mood disorder symptoms in women with ADHD (2021), PubMed abstract
  5. Broughton et al., British Journal of Psychiatry: Increased risk of provisional PMDD among females with ADHD (2025)
  6. Tsuji et al., Journal of Psychiatric Research: Association of ADHD/ASD traits with PMDD among full-time employed women in Japan (2026), PubMed abstract
  7. Lin et al., Journal of Women's Health: Comorbid ADHD in women with PMDD (2024), PubMed abstract
  8. Groenman et al., Women's Health: The monthly spectrum, premenstrual symptoms across ADHD and autism (2026)
  9. de Jong et al., Frontiers in Psychiatry: Female-specific pharmacotherapy in ADHD, premenstrual adjustment of psychostimulant dosage (2023)
  10. Prasad et al., Journal of Women's Health: Suicidal risk in women with PMS and PMDD, systematic review and meta-analysis (2021)
  11. Yan et al., Journal of Affective Disorders: Suicidality in patients with PMDD, systematic review and meta-analysis (2021), PubMed abstract
  12. National Institute of Mental Health: ADHD in Adults, 4 Things to Know (NIH Publication 24-MH-3573, 2024)
  13. DailyMed: Concerta prescribing information, boxed warning on abuse, misuse and addiction

Dealing with more than one thing at once?

Dr. Shershow's evaluation considers ADHD and what may be happening alongside it. Call, or leave your number and the office will call you.

Prefer a call back?

Leave your number and the office will call you to schedule.

No health details needed. Not for emergencies: call or text 988, or call 911.

Book AppointmentCall (212) 265-4310